US 9328142
Lipopeptide inhibitors of RAS oncoproteins
granted A61KA61K38/005A61K38/08
Quick answer
US patent 9328142 (Lipopeptide inhibitors of RAS oncoproteins) held by The United States of America, as represented by the Secretary, Department of Health and Human Services expires Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary, Department of Health and Human Services
- Grant date
- Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 28 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 22
- CPC classes
- A61K, A61K38/005, A61K38/08, A61K38/10, A61K38/1709